Skip to main content
. 2024 Oct 21;27(11):111221. doi: 10.1016/j.isci.2024.111221

Table 3.

Sensitivity/specificity analyses and receiver-operating curve models for SARC-F, SARC-CalF, and SEAC validation against different reference criteria in the development set (N = 475)

Sensitivity (%) Specificity (%) PLR NLR Cutoff point AUC
AWGS
SARC-F 16.9 (13.0–21.2) 85.3 (78.2–90.7) 1.1 (0.7–1.8) 1.0 (0.9–1.1) ≥4 0.54 (0.49–0.60)b
SARC-CalF 46.6 (41.2–52.1) 88.2 (81.6–93.1) 4.0 (2.5–6.4) 0.6 (0.5–0.7) ≥11 0.78 (0.74–0.83)
SEAC 76.4 (71.5–80.8) 77.2 (69.2–84.0) 3.4 (2.4–4.6) 0.3 (0.2–0.4) ≥6a 0.79 (0.74–0.83)
CECS
SARC-F 17.0 (13.1–21.6) 85.5 (79.0–90.7) 1.2 (0.7–1.9) 1.0 (0.9–1.1) ≥4 0.55 (0.50–0.60)b
SARC-CalF 47.1 (41.5–52.7) 85.5 (79.0–90.1) 3.2 (2.2–4.9) 0.6 (0.5–0.7) ≥11 0.76 (0.71–0.80)
SEAC 76.2 (71.1–80.7) 71.1 (63.1–78.1) 2.6 (2.0–3.4) 0.3 (0.3–0.4) ≥6a 0.76 (0.72–0.81)
IWGS
SARC-F 17.1 (13.2–21.7) 85.8 (79.1–91.0) 1.2 (0.8–1.0) 1.0 (0.9–1.0) ≥4 0.57 (0.52–0.63)b
SARC-CalF 46.2 (40.1–51.7) 84.4 (77.6–89.9) 3.0 (2.0–4.4) 0.6 (0.6–0.7) ≥11 0.74 (0.69–0.78)
SEAC 73.7 (68.6–78.4) 66.9 (58.7–74.4) 2.2 (1.8–2.8) 0.4 (0.3–0.5) ≥6a 0.74 (0.69–0.79)
EWGSOP
SARC-F 19.9 (15.2–25.1) 88.5 (83.3–92.5) 1.7 (1.1–2.7) 0.9 (0.8–0.9) ≥4 0.59 (0.54–0.64)b
SARC-CalF 50.6 (44.4–56.7) 81.3 (75.3–86.3) 2.7 (2.0–3.7) 0.6 (0.5–0.7) ≥11 0.75 (0.70–0.79)
SEAC 79.4 (74.0–84.1) 60.1 (53.1–66.8) 2.0 (1.7–2.4) 0.3 (0.3–0.4) ≥6a 0.76 (0.72–0.80)

Notes: AWGS, Asian Working Group for Sarcopenia; CECS, Chinese expert consensus on prevention and intervention for older people with sarcopenia; IWGS, International Working Group on Sarcopenia; EWGSOP, European Working Group on Sarcopenia in Older People; PLR, positive likelihood ratio; NLR, negative likelihood ratio; AUC, area under the receiver-operating characteristic curve.

Data are presented with the 95% CI in parentheses.

a

The Youden’s index (YI, YI = sensitivity + specificity − 1) was used to determine the optimum cutoff point(s).

b

Significantly different with SEAC (p < 0.05).